Low-Ogestrel NDC 51862-564

NDC codes

FDA NDC Directory

Product NDC (as listed)51862-564Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51862-0564Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51862-564-06	51862056406	6 BLISTER PACK in 1 CARTON (51862-564-06) / 1 KIT in 1 BLISTER PACK (51862-564-01)Marketed from Aug 3, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Low-Ogestrel
Generic name (nonproprietary): norgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Mayne Pharma Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075288
Marketing start: Aug 3, 2016
Marketing end: Jan 31, 2027
Identifiers: Product ID 51862-564_051f62cc-9a4a-40bc-9a9b-e7942354c0dcSPL ID 051f62cc-9a4a-40bc-9a9b-e7942354c0dcSPL set ID 8755b020-d439-4ba2-a60b-6c57a15ece55RxCUI 311359, 748797, 749786, 750244

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451862056406 followed by a unit qualifier and the quantity

Package 51862-0564-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Low-Ogestrel is indicated for use by females of reproductive potential to prevent pregnancy. In a study of 1,287 women with a total of 11,085 cycles or 852.7 women-years of usage, the pregnancy rate in women age 15-40 years was approximately 1 pregnancy per 100 women-years of use.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)